01718nas a2200253   4500000000100000008004100001260004400042653003400086653003900120653002100159653002800180653001700208100001500225700001300240700001300253700001200266700001200278245009700290856006300387300001400450490000700464520096800471022002501439       2022                            d  bCenters for Disease Control MMWR Office10aHealth Information Management10aHealth, Toxicology and Mutagenesis10aGeneral Medicine10aHealth (social science)10aEpidemiology1 aHopkins DR1 aWeiss AJ1 aYerian S1 aSapp SG1 aCama VA00aProgress Toward Global Eradication of Dracunculiasis — Worldwide, January 2021–June 2022  uhttps://www.cdc.gov/mmwr/volumes/71/wr/pdfs/mm7147a2-H.pdf  a1496-15020 v713 a<p><strong>What is already known about this topic?</strong></p>

<p>Human cases of dracunculiasis (Guinea worm disease) have decreased from an estimated 3.5 million in 1986 to 15 in 2021. Emergence of Guinea worm infections in dogs in 2012 has complicated eradication efforts.</p>

<p><strong>What is added by this report?</strong></p>

<p>Fifteen cases in humans were reported in 2021 and three during January–June 2022. As of November 2022, dracunculiasis remained endemic in five countries (Angola, Chad, Ethiopia, Mali, and South Sudan).</p>

<p><strong>What are the implications for public health practice?</strong></p>

<p>With only 15 human cases identified in 2021 and three during January–June 2022, program efforts appear to be closer to reaching the goal of eradication. However, dog infections and impeded access because of civil unrest and insecurity in Mali and South Sudan continue to be the greatest challenges for the program.</p>
  a0149-2195, 1545-861X